Piper Sandler has recently raised Intra-Cellular Therapies Inc (ITCI) stock to Overweight rating, as announced on September 6, 2024, according to Finviz. Earlier, on January 3, 2024, Robert W. Baird ...

Shake Shack Inc (SHAK) stock saw a decline, ending the day at $106.94 which represents a decrease of $-0.54 or -0.50% from the prior close of $107.48. The stock opened at $107.58 and touched a low of ...

According to Fortune Business Insights, in 2023, the hair care industry was estimated to be worth $99.52 billion globally.

In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...

In a recent transaction, Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, sold a significant amount of company ...

"Should September's positive returns hold as we expect, it would mark the fourth consecutive month of positive total returns ...

Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( LSE:0Q15) with a Overweight recommendation. What is the Fund Sentiment?

Fintel reports that on September 20, 2024, Piper Sandler downgraded their outlook for Par Pacific Holdings (NYSE:PARR) from ...

Fintel reports that on September 20, 2024, Piper Sandler downgraded their outlook for Valero Energy (NYSE:VLO) from ...

Immunome Inc. (NASDAQ:IMNM), a pharmaceutical company specializing in the development of immune-based treatments, has reported a significant transaction by its Chief Financial Officer, Max Rosett.

An action-packed week on Wall Street ends with a bang as index-tracking funds are set to reshuffle $250 billion of shares, ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...